Perna canaliculus · New Zealand mussel · GLM
300–600 mg/day · gluten-free · 60 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Green-lipped mussel is the powdered extract of Perna canaliculus, a shellfish native to New Zealand. It is rich in omega-3 fatty acids (EPA, DHA, ETA), glycosaminoglycans, and unique anti-inflammatory lipids. It has been used for both joint and respiratory conditions.
The extract contains a unique omega-3 fatty acid — eicosatetraenoic acid (ETA) — that inhibits both the cyclooxygenase and lipoxygenase pathways, potentially offering broader anti-inflammatory activity than standard fish oil. It also provides glycosaminoglycans and antioxidant carotenoids that support cartilage and reduce oxidative stress.
Adults with osteoarthritis or asthma seeking a marine-derived anti-inflammatory supplement. Best suited for those without shellfish allergies who prefer whole-food extracts over isolated compounds.
Absolute contraindication for shellfish allergy. Not for pregnancy or breastfeeding. Use caution with anticoagulant medications due to omega-3 content.
Pick a depth — minimum to maximal coverage
No full stack configured.
Click individual supplement pills above to buy each on Amazon India.
✓ Divided dosing maintains more stable anti-inflammatory activity throughout the day.
✓ Divided dosing maintains more stable anti-inflammatory activity throughout the day.
✓ Food improves absorption of the lipid-soluble omega-3 and carotenoid components.
The extract contains a unique omega-3 fatty acid — eicosatetraenoic acid (ETA) — that inhibits both the cyclooxygenase and lipoxygenase pathways, potentially offering broader anti-inflammatory activity than standard fish oil.
Each bar = one cited trial. Effect varies by methodology, dose, and population.
Knee OA cohort (n≈60, VAS scale)
VAS pain scale 0–10. Lower = less pain.
see study
→ Meta-analysis of 5 RCTs: green-lipped mussel showed significant improvement in joint pain and stiffness versus placebo in OA patients.
see study
→ RCT: stabilized lipid extract significantly reduced daytime wheeze, asthma severity, and rescue medication use versus placebo in asthma patients.
see study
→ Review documented anti-inflammatory mechanisms including COX and lipoxygenase inhibition, plus clinical evidence for OA and respiratory conditions.
C · Small-to-moderate RCTs show modest benefits for OA pain and asthma symptoms. Meta-analytic support exists but is limited by small study numbers. Shellfish allergy is an absolute barrier for many consumers.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: PMID 23054738, PMID 12723986, PMID 23783247
How to use Green-Lipped Mussel specifically for knee pain — the right dose, timing, blood markers to track, and how to know if it is working.
A clinical evidence review of Green-Lipped Mussel — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Everything you need to know about Green-Lipped Mussel — mechanism, dose, safety, buying guide for India, and what the research actually says.
SacredBod's longer take on Green-Lipped Mussel — context the structured blocks above don't capture.
Green-lipped mussel — Perna canaliculus — is one of New Zealand’s most distinctive marine exports, valued not as food but as a therapeutic extract. The green-tinged edges of its shell give it its name, but its pharmacological interest lies in its unique lipid profile. Unlike standard fish oil, which primarily provides EPA and DHA, green-lipped mussel contains eicosatetraenoic acid (ETA) — an omega-3 fatty acid that inhibits both the cyclooxygenase (COX) and lipoxygenase (LOX) inflammatory pathways simultaneously. This dual inhibition theoretically offers broader anti-inflammatory coverage than NSAIDs, which typically target only COX.
The clinical evidence is modest but consistent. A 2012 meta-analysis in Inflammopharmacology pooled five randomized controlled trials and found that green-lipped mussel extract significantly improved joint pain and stiffness in osteoarthritis patients compared to placebo. The effect size was not dramatic — this is not a replacement for diclofenac — but the safety profile is considerably more favorable than chronic NSAID use. A 2003 study in the European Respiratory Journal demonstrated that a stabilized lipid extract (Lyprinol) significantly reduced daytime wheeze, asthma severity scores, and rescue bronchodilator use in asthma patients over eight weeks, suggesting applications beyond joint health.
The quality of the extract matters enormously. Green-lipped mussel supplements come in two primary forms: freeze-dried powder and stabilized lipid extract. The stabilized lipid extracts (which protect the omega-3 fatty acids from oxidation) have demonstrated more consistent clinical results than simple freeze-dried powder. Consumers should look for products that specify “stabilized lipid extract” or “PCS0-85” — the proprietary extraction process that preserves the bioactive lipids.
The shellfish allergy issue is non-negotiable. Green-lipped mussel is a bivalve mollusk, and individuals with shellfish allergies should avoid it entirely. Cross-reactivity with crustacean allergies (shrimp, crab) is possible but not guaranteed — mollusks and crustaceans are taxonomically distinct. However, given the potential for severe allergic reactions, anyone with any shellfish allergy should consult an allergist before considering this supplement.
For consumers without shellfish allergies who are seeking a marine-derived anti-inflammatory with a different mechanism than standard fish oil, green-lipped mussel is a reasonable option. It is best used as part of a comprehensive joint health protocol rather than a standalone solution, with expectations calibrated to the modest but genuine evidence base.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
